Linkage and exome analysis implicate multiple genes in non-syndromic intellectual disability in a large Swedish family.
1-Acylglycerol-3-Phosphate O-Acyltransferase
/ genetics
DNA Copy Number Variations
Exome
/ genetics
Genetic Linkage
Humans
Intellectual Disability
/ genetics
Jumonji Domain-Containing Histone Demethylases
/ genetics
Karyotyping
MAP Kinase Kinase Kinase 4
/ genetics
Organic Anion Transporters
/ genetics
Pedigree
Polymorphism, Single Nucleotide
Sweden
Symporters
/ genetics
Exome Sequencing
Affymetrix genome-wide human SNP Array 6.0
Complex disorder
Genome wide analysis
Large pedigree
Sequencing
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
06 11 2019
06 11 2019
Historique:
received:
11
02
2019
accepted:
18
10
2019
entrez:
8
11
2019
pubmed:
7
11
2019
medline:
3
4
2020
Statut:
epublish
Résumé
Non-syndromic intellectual disability is genetically heterogeneous with dominant, recessive and complex forms of inheritance. We have performed detailed genetic studies in a large multi-generational Swedish family, including several members diagnosed with non-syndromic intellectual disability. Linkage analysis was performed on 22 family members, nine affected with mild to moderate intellectual disability and 13 unaffected family members. Family members were analyzed with Affymetrix Genome-Wide Human SNP Array 6.0 and the genetic data was used to detect copy number variation and to perform genome wide linkage analysis with the SNP High Throughput Linkage analysis system and the Merlin software. For the exome sequencing, the samples were prepared using the Sure Select Human All Exon Kit (Agilent Technologies, Santa Clara, CA, USA) and sequenced using the Ion Proton™ System. Validation of identified variants was performed with Sanger sequencing. The linkage analysis results indicate that intellectual disability in this family is genetically heterogeneous, with suggestive linkage found on chromosomes 1q31-q41, 4q32-q35, 6p25 and 14q24-q31 (LOD scores of 2.4, simulated p-value of 0.000003 and a simulated genome-wide p-value of 0.06). Exome sequencing was then performed in 14 family members and 7 unrelated individuals from the same region. The analysis of coding variation revealed a pathogenic and candidate variants in different branches of the family. In three patients we find a known homozygous pathogenic mutation in the Homo sapiens solute carrier family 17 member 5 (SLC17A5), causing Salla disease. We also identify a deletion overlapping KDM3B and a duplication overlapping MAP3K4 and AGPAT4, both overlapping variants previously reported in developmental disorders. DNA samples from the large family analyzed in this study were initially collected based on a hypothesis that affected members shared a major genetic risk factor. Our results show that a complex phenotype such as mild intellectual disability in large families from genetically isolated populations may show considerable genetic heterogeneity.
Sections du résumé
BACKGROUND
Non-syndromic intellectual disability is genetically heterogeneous with dominant, recessive and complex forms of inheritance. We have performed detailed genetic studies in a large multi-generational Swedish family, including several members diagnosed with non-syndromic intellectual disability. Linkage analysis was performed on 22 family members, nine affected with mild to moderate intellectual disability and 13 unaffected family members.
METHODS
Family members were analyzed with Affymetrix Genome-Wide Human SNP Array 6.0 and the genetic data was used to detect copy number variation and to perform genome wide linkage analysis with the SNP High Throughput Linkage analysis system and the Merlin software. For the exome sequencing, the samples were prepared using the Sure Select Human All Exon Kit (Agilent Technologies, Santa Clara, CA, USA) and sequenced using the Ion Proton™ System. Validation of identified variants was performed with Sanger sequencing.
RESULTS
The linkage analysis results indicate that intellectual disability in this family is genetically heterogeneous, with suggestive linkage found on chromosomes 1q31-q41, 4q32-q35, 6p25 and 14q24-q31 (LOD scores of 2.4, simulated p-value of 0.000003 and a simulated genome-wide p-value of 0.06). Exome sequencing was then performed in 14 family members and 7 unrelated individuals from the same region. The analysis of coding variation revealed a pathogenic and candidate variants in different branches of the family. In three patients we find a known homozygous pathogenic mutation in the Homo sapiens solute carrier family 17 member 5 (SLC17A5), causing Salla disease. We also identify a deletion overlapping KDM3B and a duplication overlapping MAP3K4 and AGPAT4, both overlapping variants previously reported in developmental disorders.
CONCLUSIONS
DNA samples from the large family analyzed in this study were initially collected based on a hypothesis that affected members shared a major genetic risk factor. Our results show that a complex phenotype such as mild intellectual disability in large families from genetically isolated populations may show considerable genetic heterogeneity.
Identifiants
pubmed: 31694657
doi: 10.1186/s12920-019-0606-4
pii: 10.1186/s12920-019-0606-4
pmc: PMC6833288
doi:
Substances chimiques
Organic Anion Transporters
0
Symporters
0
sialic acid transport proteins
0
Jumonji Domain-Containing Histone Demethylases
EC 1.14.11.-
KDM3B protein, human
EC 1.14.11.-
1-Acylglycerol-3-Phosphate O-Acyltransferase
EC 2.3.1.51
MAP Kinase Kinase Kinase 4
EC 2.7.11.25
MAP3K4 protein, human
EC 2.7.11.25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
156Références
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Nucleic Acids Res. 2012 Jan;40(Database issue):D13-25
pubmed: 22140104
Arch Iran Med. 2015 Oct;18(10):670-82
pubmed: 26443249
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Am J Med Genet A. 2006 Oct 1;140(19):2063-74
pubmed: 16917849
Am J Hum Genet. 1997 Aug;61(2):379-87
pubmed: 9311743
Nat Rev Mol Cell Biol. 2012 Nov;13(11):687-99
pubmed: 23090414
Eur J Hum Genet. 2016 Mar;24(3):392-9
pubmed: 26173967
Brain. 2006 Jul;129(Pt 7):1892-906
pubmed: 16684786
Mol Psychiatry. 2016 Jan;21(1):133-48
pubmed: 25644381
Nat Rev Genet. 2005 Jan;6(1):46-57
pubmed: 15630421
Curr Genomics. 2018 Aug;19(5):327-338
pubmed: 30065609
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
PLoS One. 2012;7(1):e29921
pubmed: 22253824
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Am J Hum Genet. 2006 Jun;78(6):922-35
pubmed: 16685644
Res Dev Disabil. 2011 Mar-Apr;32(2):419-36
pubmed: 21236634
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
AJNR Am J Neuroradiol. 1999 Mar;20(3):433-43
pubmed: 10219409
Trends Genet. 2014 Jan;30(1):32-9
pubmed: 24176302
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Nat Rev Genet. 2015 May;16(5):275-84
pubmed: 25824869
Hum Mol Genet. 2012 Sep 15;21(18):4038-48
pubmed: 22694955
BMC Bioinformatics. 2009 Apr 24;10:121
pubmed: 19393044
J Neurodev Disord. 2010 Dec;2(4):182-209
pubmed: 21124998
Annu Rev Genomics Hum Genet. 2010;11:161-87
pubmed: 20822471
Eur J Hum Genet. 2008 Jul;16(7):854-60
pubmed: 18301450
Trends Endocrinol Metab. 2004 Jan-Feb;15(1):34-9
pubmed: 14693424
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Genet Med. 2011 Sep;13(9):777-84
pubmed: 21844811
PLoS One. 2015 Aug 26;10(8):e0129631
pubmed: 26308914
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
Am J Hum Genet. 2012 May 4;90(5):847-55
pubmed: 22541559
Clin Genet. 1986 Nov;30(5):374-80
pubmed: 3802556
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92
pubmed: 24174537
Neuron. 1998 Dec;21(6):1315-25
pubmed: 9883725
BMC Med Genet. 2008 Feb 06;9:6
pubmed: 18254962
Proteins. 2006 Mar 1;62(4):1125-32
pubmed: 16372356
J Neural Transm (Vienna). 2015 Sep;122(9):1289-301
pubmed: 25626716
J Hum Genet. 2017 Jul;62(7):733-735
pubmed: 28275241
Am J Hum Genet. 2019 Apr 4;104(4):758-766
pubmed: 30929739
N Engl J Med. 2012 Feb 23;366(8):733-43
pubmed: 22356326
Hum Mol Genet. 2011 May 15;20(10):1886-92
pubmed: 21330303
Bioinformatics. 2007 May 15;23(10):1289-91
pubmed: 17379693
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590